The high-profile trial of former Theranos CEO Elizabeth Holmes boils down to a single question: Did she cover up defects in her startup’s blood-testing technology to rip off investors while potentially endangering the lives of unwitting patients Closing arguments underway in Elizabeth Holmes criminal trial SAN JOSE, Calif. — TheContinue Reading